Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Price to Earnings (2022 - 2026)

Updated

Theravance Biopharma's (TBPH) Price to Earnings was 16.39 for Q2 2026, down 61.5% from 42.63 a year earlier but up 124.6% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Price to Earnings (2022 - 2026) Analysis & Trends

For FY2025, Price to Earnings at Theravance Biopharma was 9.02.

  • By year, Price to Earnings came in at 0.84 in FY2022.
  • Five-year quarterly Price to Earnings spans a low of 0.64 in Q2 2023 and a high of 42.63 in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 7.30 (Q1 2026), 9.02 (Q4 2025) and 25.21 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.39
Mar 31, 2026 7.30
Dec 31, 2025 9.02
Sep 30, 2025 25.21
Jun 30, 2025 42.63
Jun 30, 2023 0.64
Mar 31, 2023 0.75
Dec 31, 2022 0.84
Sep 30, 2022 0.80
API Access

Theravance Biopharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TBPH&period=max&api_key=YOUR_API_KEY